Latest Breaking News On - Jocelyn fernandes - Page 1 : vimarsana.com

COVID-19 Vaccine | Sanofi and GSK’s vaccine said to produce strong immune responses in mid-stage study Jocelyn Fernandes © Jocelyn Fernandes COVID-19 Vaccine | Sanofi and GSK’s vaccine said to produce strong immune responses in mid-stage study Rebecca Robbins Sanofi, the French pharmaceutical company, said Monday that it would move the experimental COVID-19 vaccine it is developing with GlaxoSmithKline into a late-stage trial after the shot produced strong immune responses in volunteers in a mid-stage study. The findings are encouraging news for a vaccine that has fallen behind in development and has so far disappointed those expecting that it would be crucial in combating the pandemic. If the vaccine can become available in the last three months of this year, as its developers hope, it could still play a central role as a booster shot as well as an initial inoculation in the developing world, where the pace of vaccination is lagging.

New yorkUnited statesSouth africaRebecca robbinsJocelyn fernandesYork times companyEuropean unionOperation warp speedLatin americaNew york timesபுதியது யார்க்ஒன்றுபட்டது மாநிலங்களில்ரிபேக்க ராபின்ஸ்ஜாஸ்லைந் பெர்னாண்டஸ்யார்க் முறை நிறுவனம்ஐரோப்பிய தொழிற்சங்கம்